跳至主要内容
临床试验/NCT00372502
NCT00372502已完成不适用

Lactate Assessment in the Treatment of Early Sepsis: The LactATES Trial

National Institute of General Medical Sciences (NIGMS)3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
3
主要终点
Mortality

研究概览

简要总结

The purpose of this study is to determine if there is equivalence between two different methods of treating patients with severe bloodstream infection called sepsis. We will randomly assign patients to one of two treatment methods. One of the treatment methods is the current standard of care and uses an infrared sensor on the end of a catheter to determine the adequacy of treatment. The second treatment method is identical to the first but instead of the infrared sensor a blood test that is performed as a part of standard care (with blood drawn from the catheter) will be used to determine the adequacy of treatment. This study will attempt to determine an easier method of guiding treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Suspected infection
  • Any two of four criteria of systemic inflammatory response
  • SBP < 90 mm Hg after 20cc/kg crystalloid (septic shock) or either a whole blood lactate > 4 mmol/L (severe sepsis).

排除标准

  • Age < 18 years
  • Established "Do Not Resuscitate" orders prior to enrollment
  • Primary diagnosis other than sepsis
  • Requirement for immediate surgery in < 6 hours from admission
  • Any absolute contraindication to central venous catheterization

结局指标

主要结局

Mortality

时间窗: In-hospital

次要结局

未报告次要终点

研究者

发起方
National Institute of General Medical Sciences (NIGMS)
申办方类型
Nih

研究点 (3)

Loading locations...

相似试验